EMAIL THIS PAGE TO A FRIEND

Journal of medicinal chemistry

Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation.


PMID 22417091

Abstract

Lactate dehydrogenase A (LDHA) catalyzes the conversion of pyruvate to lactate, utilizing NADH as a cofactor. It has been identified as a potential therapeutic target in the area of cancer metabolism. In this manuscript we report our progress using fragment-based lead generation (FBLG), assisted by X-ray crystallography to develop small molecule LDHA inhibitors. Fragment hits were identified through NMR and SPR screening and optimized into lead compounds with nanomolar binding affinities via fragment linking. Also reported is their modification into cellular active compounds suitable for target validation work.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

O3750
Oxamic acid, ≥98%
C2H3NO3